Published in Biochemistry on September 09, 1997
A specific cholesterol binding site is established by the 2.8 A structure of the human beta2-adrenergic receptor. Structure (2008) 6.01
Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta (2007) 3.83
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A (2001) 2.87
Critical role for cholesterol in Lyn-mediated tyrosine phosphorylation of FcepsilonRI and their association with detergent-resistant membranes. J Cell Biol (1999) 2.30
Oxysterols stimulate Sonic hedgehog signal transduction and proliferation of medulloblastoma cells. Proc Natl Acad Sci U S A (2006) 2.23
Use of thiol-disulfide equilibria to measure the energetics of assembly of transmembrane helices in phospholipid bilayers. Proc Natl Acad Sci U S A (2003) 1.82
Determination of membrane cholesterol partition coefficient using a lipid vesicle-cyclodextrin binary system: effect of phospholipid acyl chain unsaturation and headgroup composition. Biophys J (2002) 1.65
Membrane cholesterol content modulates activation of volume-regulated anion current in bovine endothelial cells. J Gen Physiol (2000) 1.59
Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol. Biophys J (2002) 1.53
Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J Biol Chem (2003) 1.52
Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J Biol Chem (2008) 1.34
Acute cholesterol depletion impairs functional expression of tissue factor in fibroblasts: modulation of tissue factor activity by membrane cholesterol. Blood (2004) 1.27
Role of cholesterol in formation and function of a signaling complex involving alphavbeta3, integrin-associated protein (CD47), and heterotrimeric G proteins. J Cell Biol (1999) 1.26
Agonist-induced endocytosis of CC chemokine receptor 5 is clathrin dependent. Mol Biol Cell (2004) 1.24
Membrane cholesterol: a crucial molecule affecting interactions of microbial pathogens with mammalian cells. Infect Immun (2005) 1.22
A role for a specific cholesterol interaction in stabilizing the Apo configuration of the human A(2A) adenosine receptor. Structure (2009) 1.19
Low cholesterol triggers membrane microdomain-dependent CD44 shedding and suppresses tumor cell migration. J Biol Chem (2010) 1.19
Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. Mol Biol Cell (2003) 1.18
Structural and dynamic effects of cholesterol at preferred sites of interaction with rhodopsin identified from microsecond length molecular dynamics simulations. Proteins (2009) 1.16
The multidrug transporter, P-glycoprotein, actively mediates cholesterol redistribution in the cell membrane. Proc Natl Acad Sci U S A (2002) 1.15
Tubular system volume changes in twitch fibres from toad and rat skeletal muscle assessed by confocal microscopy. J Physiol (2002) 1.15
The role of cholesterol in rod outer segment membranes. Prog Lipid Res (2005) 1.13
LCP-Tm: an assay to measure and understand stability of membrane proteins in a membrane environment. Biophys J (2010) 1.13
Glutamate-binding affinity of Drosophila metabotropic glutamate receptor is modulated by association with lipid rafts. Proc Natl Acad Sci U S A (2003) 1.10
Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor. Proc Natl Acad Sci U S A (2012) 1.09
Direct regulation of prokaryotic Kir channel by cholesterol. J Biol Chem (2009) 1.09
Cholesterol organization in membranes at low concentrations: effects of curvature stress and membrane thickness. Biophys J (2001) 1.06
Sterol carrier protein-2: new roles in regulating lipid rafts and signaling. Biochim Biophys Acta (2007) 1.04
Fluorescence techniques using dehydroergosterol to study cholesterol trafficking. Lipids (2008) 1.03
Specificity of cholesterol and analogs to modulate BK channels points to direct sterol-channel protein interactions. J Gen Physiol (2010) 1.01
Cholesterol effect on the dipole potential of lipid membranes. Biophys J (2006) 1.00
Quantitative differences in lipid raft components between murine CD4+ and CD8+ T cells. BMC Immunol (2004) 0.98
Sensitivity of volume-regulated anion current to cholesterol structural analogues. J Gen Physiol (2004) 0.98
Differential effect of membrane cholesterol removal on mu- and delta-opioid receptors: a parallel comparison of acute and chronic signaling to adenylyl cyclase. J Biol Chem (2009) 0.96
Interaction of melittin with membrane cholesterol: a fluorescence approach. Biophys J (2004) 0.96
Large conductance, calcium- and voltage-gated potassium (BK) channels: regulation by cholesterol. Pharmacol Ther (2012) 0.96
Effects of membrane cholesterol manipulation on excitation-contraction coupling in skeletal muscle of the toad. J Physiol (2001) 0.96
G-protein coupled receptor solubilization and purification for biophysical analysis and functional studies, in the total absence of detergent. Biosci Rep (2015) 0.95
Predictions for cholesterol interaction sites on the A2A adenosine receptor. J Am Chem Soc (2012) 0.95
Influence of membrane cholesterol on modulation of the GABA(A) receptor by neuroactive steroids and other potentiators. Br J Pharmacol (2001) 0.94
Membrane cholesterol modulates dihydropyridine receptor function in mice fetal skeletal muscle cells. J Physiol (2004) 0.93
The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj J (2008) 0.93
Differential sensitivity of types 1 and 2 cholecystokinin receptors to membrane cholesterol. J Lipid Res (2011) 0.93
Yeast and cancer cells - common principles in lipid metabolism. Biochim Biophys Acta (2012) 0.92
Cholesterol accelerates the binding of Alzheimer's β-amyloid peptide to ganglioside GM1 through a universal hydrogen-bond-dependent sterol tuning of glycolipid conformation. Front Physiol (2013) 0.91
Cholesterol modulates open probability and desensitization of NMDA receptors. J Physiol (2015) 0.91
Smooth muscle cholesterol enables BK β1 subunit-mediated channel inhibition and subsequent vasoconstriction evoked by alcohol. Arterioscler Thromb Vasc Biol (2011) 0.89
Sensitivity of cholecystokinin receptors to membrane cholesterol content. Front Endocrinol (Lausanne) (2012) 0.87
Structure and cholesterol domain dynamics of an enriched caveolae/raft isolate. Biochem J (2004) 0.87
The role of cell cholesterol and the cytoskeleton in the interaction between IK1 and maxi-K channels. Am J Physiol Cell Physiol (2009) 0.86
A predicted binding site for cholesterol on the GABAA receptor. Biophys J (2014) 0.86
Actinobacterial acyl coenzyme A synthetases involved in steroid side-chain catabolism. J Bacteriol (2013) 0.85
Asymmetric requirement for cholesterol in receptor-bearing but not envelope-bearing membranes for fusion mediated by ecotropic murine leukemia virus. J Virol (2002) 0.84
Cholesterol activates the G-protein coupled receptor Smoothened to promote Hedgehog signaling. Elife (2016) 0.83
Purification of recombinant acyl-coenzyme A:cholesterol acyltransferase 1 (ACAT1) from H293 cells and binding studies between the enzyme and substrates using difference intrinsic fluorescence spectroscopy. Biochemistry (2010) 0.83
Critical role of diacylglycerol- and phospholipid-regulated protein kinase C epsilon in induction of low-density lipoprotein receptor transcription in response to depletion of cholesterol. Mol Cell Biol (2002) 0.82
G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids. Int J Mol Sci (2014) 0.82
The role of cholesterol in membrane fusion. Chem Phys Lipids (2016) 0.82
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling. Br J Pharmacol (2012) 0.80
The influence of oxidation of membrane thiol groups on lysosomal proton permeability. Biochem J (2001) 0.79
New fluorescent cholesterol analogs as membrane probes. Biochim Biophys Acta (1999) 0.79
Stereospecific requirement of cholesterol in the function of the serotonin1A receptor. Biochim Biophys Acta (2013) 0.79
Progesterone inhibits oxytocin- and prostaglandin F2alpha-stimulated increases in intracellular calcium concentrations in small and large ovine luteal cells. Biol Reprod (2009) 0.78
Long chain polyunsaturated fatty acids alter oxytocin signaling and receptor density in cultured pregnant human myometrial smooth muscle cells. PLoS One (2012) 0.78
Mechanosensory Signaling in Enterochromaffin Cells and 5-HT Release: Potential Implications for Gut Inflammation. Front Neurosci (2016) 0.78
Two classes of cholesterol binding sites for the β2AR revealed by thermostability and NMR. Biophys J (2014) 0.77
Interaction of alpha-tocopherol with model human high-density lipoproteins. Biophys J (1998) 0.77
Decrease of P-glycoprotein activity in K562/ADR cells by MbetaCD and filipin and lack of effect induced by cholesterol oxidase indicate that this transporter is not located in rafts. J Bioenerg Biomembr (2004) 0.76
Resistance to degradation and cellular distribution are important features for the antitumor activity of gomesin. PLoS One (2013) 0.76
Pentameric Ligand-gated Ion Channels : Insights from Computation. Mol Simul (2014) 0.76
Cholesterol up-regulates neuronal G protein-gated inwardly rectifying potassium (GIRK) channel activity in the hippocampus. J Biol Chem (2017) 0.75
Mechanism of allosteric regulation of β2-adrenergic receptor by cholesterol. Elife (2016) 0.75
Design, synthesis and biological activity of new neurohypophyseal hormones analogues conformationally restricted in the N-terminal part of the molecule. Highly potent OT receptor antagonists. Amino Acids (2011) 0.75
Using Sterol Substitution to Probe the Role of Membrane Domains in Membrane Functions. Lipids (2015) 0.75
Impact of Lipid Composition and Receptor Conformation on the Spatio-temporal Organization of μ-Opioid Receptors in a Multi-component Plasma Membrane Model. PLoS Comput Biol (2016) 0.75
Membrane cholesterol access into a G-protein-coupled receptor. Nat Commun (2017) 0.75
Reduced Membrane Cholesterol Limits Pulmonary Endothelial Ca(2+) Entry Following Chronic Hypoxia. Am J Physiol Heart Circ Physiol (2017) 0.75
Interaction of serotonin1A receptors from bovine hippocampus with tertiary amine local anesthetics. Cell Mol Neurobiol (2004) 0.75
Oxytocin (OXT)-stimulated inhibition of Kir7.1 activity is through PIP2-dependent Ca(2+) response of the oxytocin receptor in the retinal pigment epithelium in vitro. Cell Signal (2017) 0.75
The oxytocin receptor system: structure, function, and regulation. Physiol Rev (2001) 6.97
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85
Cholesterol binds to synaptophysin and is required for biogenesis of synaptic vesicles. Nat Cell Biol (2000) 3.55
Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry (1995) 3.36
Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10. Proc Natl Acad Sci U S A (2001) 2.87
Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. J Cell Biol (2001) 2.20
Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J Clin Endocrinol Metab (1998) 1.70
Regulation of receptor function by cholesterol. Cell Mol Life Sci (2000) 1.67
Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J (2001) 1.47
Subcellular localization of the human proto-oncogene protein DEK. J Biol Chem (2001) 1.39
First synthesis of totally orthogonal protected alpha-(trifluoromethyl)- and alpha-(difluoromethyl)arginines. J Org Chem (2001) 1.37
Transbilayer movement of fluorescent and spin-labeled phospholipids in the plasma membrane of human fibroblasts: a quantitative approach. J Cell Sci (1996) 1.20
Cloning and nucleotide sequence of the structural genes encoding the formate dehydrogenase of Wolinella succinogenes. Arch Microbiol (1991) 1.10
Effects of pentoxifylline on hemorheologic alterations induced by incremental treadmill exercise in thoroughbreds. Am J Vet Res (1996) 1.10
The quinone-reactive Ni/Fe-hydrogenase of Wolinella succinogenes. Eur J Biochem (1992) 1.07
Isolation of intact FNR protein (Mr 30,000) of Escherichia coli. Mol Microbiol (1990) 1.04
Cloning and nucleotide sequence of the psrA gene of Wolinella succinogenes polysulphide reductase. Eur J Biochem (1992) 1.03
Inflammatory cytokine expression in swine experimentally infected with Actinobacillus pleuropneumoniae. Infect Immun (1995) 1.03
Solvation phenomena of a tetrapeptide in water/trifluoroethanol and water/ethanol mixtures: a diffusion NMR, intermolecular NOE, and molecular dynamics study. J Am Chem Soc (2002) 1.02
Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem (2000) 1.02
Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry (1995) 1.01
Molecular cloning of a new bombesin receptor subtype expressed in uterus during pregnancy. Eur J Biochem (1992) 1.01
Evidence of complete hydrophobic coating of bombesin by trifluoroethanol in aqueous solution: an NMR spectroscopic and molecular dynamics study. Chemistry (2002) 0.99
The amino-terminal fragment of the adenylate cyclase activating polypeptide (PACAP) receptor functions as a high affinity PACAP binding domain. Biochem Biophys Res Commun (1995) 0.98
An extracellular residue determines the agonist specificity of V2 vasopressin receptors. FEBS Lett (1995) 0.97
Lymphoma imaging with a new technetium-99m labelled antibody, LL2. Eur J Nucl Med (1992) 0.97
Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach. Cell Tissue Res (2000) 0.96
Effects of neuron-specific ADAM10 modulation in an in vivo model of acute excitotoxic stress. Neuroscience (2008) 0.96
S-type lectins occur also in invertebrates: high conservation of the carbohydrate recognition domain in the lectin genes from the marine sponge Geodia cydonium. Glycobiology (1993) 0.95
Agonist and antagonist-dependent internalization of the human vasopressin V2 receptor. Exp Cell Res (1998) 0.91
Direct identification of an extracellular agonist binding site in the renal V2 vasopressin receptor. Biochemistry (1993) 0.91
Periplasmic sulphide dehydrogenase (Sud) from Wolinella succinogenes: isolation, nucleotide sequence of the sud gene and its expression in Escherichia coli. Eur J Biochem (1995) 0.90
Separate agonist and peptide antagonist binding sites of the oxytocin receptor defined by their transfer into the V2 vasopressin receptor. J Biol Chem (1996) 0.90
Detection of a new hormone contact site within the insulin receptor ectodomain by the use of a novel photoreactive insulin. J Biol Chem (1992) 0.90
Oxytocin receptors and cholesterol: interaction and regulation. Exp Physiol (2000) 0.88
Derivatives of somatic cell hybrids which carry the human gene locus for nephrogenic diabetes insipidus (NDI) express functional vasopressin renal V2-type receptors. J Biol Chem (1990) 0.88
Protein-mediated inward translocation of phospholipids occurs in both the apical and basolateral plasma membrane domains of epithelial cells. Biochemistry (1999) 0.88
Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line. Eur J Biochem (1993) 0.87
Photocleavable biotinylated ligands for affinity chromatography. Anal Biochem (1994) 0.87
Differential inactivation of vasopressin receptor subtypes in isolated membranes and intact cells by N-ethylmaleimide. FEBS Lett (1990) 0.86
Reconstitution of the myometrial oxytocin receptor into proteoliposomes. Dependence of oxytocin binding on cholesterol. Eur J Biochem (1994) 0.86
The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature. EMBO J (1989) 0.86
Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics (1992) 0.86
Autoradiographic localization of V1 vasopressin binding sites in rat brain and kidney. Eur J Pharmacol (1989) 0.85
Direct identification of the agonist binding site in the human brain cholecystokininB receptor. Biochemistry (1999) 0.84
Photoaffinity labelling of the renal V2 vasopressin receptor. Identification and enrichment of a vasopressin-binding subunit. Eur J Biochem (1985) 0.83
Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens (2003) 0.83
Ligand-induced cleavage of the V2 vasopressin receptor by a plasma membrane metalloproteinase. J Biol Chem (1995) 0.83
Major proteolytic fragments of the murine band 3 protein as obtained after in situ proteolysis. Biochim Biophys Acta (1989) 0.83
Workshop studies with monoclonal antibodies identifying a novel porcine differentiation antigen, SWC9. Vet Immunol Immunopathol (1998) 0.83
Organization and chromosomal localization of the gene for the human bombesin receptor subtype expressed in pregnant uterus. FEBS Lett (1994) 0.82
Non-genomic effects of progesterone on the signaling function of G protein-coupled receptors. FEBS Lett (1999) 0.82
Vasopressin V2-receptor mobile fraction and ligand-dependent adenylate cyclase activity are directly correlated in LLC-PK1 renal epithelial cells. J Cell Biol (1991) 0.82
Lateral mobility of the phospholipase C-activating vasopressin V1-type receptor in A7r5 smooth muscle cells: a comparison with the adenylate cyclase-coupled V2-receptor. EMBO J (1990) 0.81
Treatment of progressive or recurrent pediatric malignant supratentorial brain tumors with herpes simplex virus thymidine kinase gene vector-producer cells followed by intravenous ganciclovir administration. J Neurosurg (2000) 0.81
[Unusual coordination behavior of D-fructose towards dimethyltin(IV)2+: metal-promoted deprotonation of alcoholic hydroxyl groups in aqueous solutions at low pH]. Acta Pharm Hung (1999) 0.81
Interactions of vasopressin agonists and antagonists with membrane receptors. Eur J Pharmacol (1984) 0.81
Cloning and functional characterization of the amphibian mesotocin receptor, a member of the oxytocin/vasopressin receptor superfamily. Eur J Biochem (1996) 0.81
Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver. J Biol Chem (1985) 0.80
Misfolded vasopressin V2 receptors caused by extracellular point mutations entail congential nephrogenic diabetes insipidus. Mol Cell Endocrinol (2000) 0.80
Molecular cloning of substance P receptor cDNA from guinea-pig uterus. Biochim Biophys Acta (1992) 0.79
Photoaffinity labeling of the human brain cholecystokinin receptor overexpressed in insect cells. Solubilization, deglycosylation and purification. Eur J Biochem (1996) 0.79
Ammonium chloride affects receptor number and lateral mobility of the vasopressin V2-type receptor in the plasma membrane of LLC-PK1 renal epithelial cells: role of the cytoskeleton. Exp Cell Res (1990) 0.79
Photoaffinity labelling of the oxytocin receptor in plasma membranes from rat mammary gland. FEBS Lett (1989) 0.79
Solubilization of ligand-stabilized vasopressin receptors from plasma membranes of bovine kidney and rat liver. Biochem Biophys Res Commun (1983) 0.79
Synthesis of p-amino-L-phenylalanine derivatives with protected p-amino group for preparation of p-azido-L-phenylalanine peptides. Int J Pept Protein Res (1980) 0.79
N-glycosylation plays a role in biosynthesis and internalization of the adenylate cyclase stimulating vasopressin V2-receptor of LLC-PK1 renal epithelial cells: an effect of concanavalin A on binding and expression. Arch Biochem Biophys (1992) 0.78
Porcine myelomonocytic markers: summary of the Second International Swine CD Workshop. Vet Immunol Immunopathol (1998) 0.78
Affinities of reactive vasopressin analogues for bovine antidiuretic receptor. Mol Cell Endocrinol (1983) 0.78
Photoaffinity labeling of central cholecystokinin receptors with high efficiency. Biochemistry (1993) 0.78
Peptide modification by introduction ofα-trifluoromethyl substituted amino acids. Amino Acids (1995) 0.78
Reactivity of the N-terminal cysteine residues in active and inactive forms of FNR, and O2-responsive, Fe containing transcriptional regulator of Escherichia coli. J Inorg Biochem (1996) 0.78
Abbreviated nomenclature for cyclic and branched homo- and hetero-detic peptides. J Pept Res (2005) 0.78
Identification and enzymatic deglycosylation of the myometrial oxytocin receptor using a radioiodinated photoreactive antagonist. J Biol Chem (1991) 0.78
A low affinity vasopressin V2-receptor in inherited nephrogenic diabetes insipidus. J Recept Res (1992) 0.78
Body fat distribution in men with angiographically confirmed coronary artery disease. Atherosclerosis (1990) 0.78
Monensin-resistant LLC-PK1 cell mutants are affected in recycling of the adenylate cyclase-stimulating vasopressin V2-receptor. Mol Cell Endocrinol (1991) 0.78
Long-term stimulation of cAMP production in LLC-PK1 pig kidney epithelial cells by salmon calcitonin or a photoactivatable analogue of vasopressin. Biochim Biophys Acta (1987) 0.78
Identification of neurohypophysial hormone receptor domains involved in ligand binding and G protein coupling. Adv Exp Med Biol (1998) 0.77
Iodinated photoreactive vasopressin antagonists: labelling of hepatic vasopressin receptor subunits. Eur J Biochem (1986) 0.77
Molecular modelling study of the role of cholesterol in the stimulation of the oxytocin receptor. Acta Biochim Pol (2001) 0.77
A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation. FEBS Lett (2000) 0.77
Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells. Biochim Biophys Acta (1994) 0.77
Sex hormone concentrations in men with angiographically assessed coronary artery disease--relationship to obesity and body fat distribution. Klin Wochenschr (1991) 0.77
Determination of the functional molecular size of vasopressin isoreceptors. FEBS Lett (1984) 0.77
Lack of interaction of vasopressin with its antisense peptides: a functional and immunological study. J Recept Res (1993) 0.77
Photoaffinity labeling analysis of the interaction of pituitary adenylate-cyclase-activating polypeptide (PACAP) with the PACAP type I receptor. Eur J Biochem (1997) 0.77
Structural requirements for V2 vasopressin receptor proteolytic cleavage. Eur J Biochem (1999) 0.77
Proteolytically stable peptides by incorporation of alpha-Tfm amino acids. J Pept Sci (1997) 0.76
The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations. Am J Obstet Gynecol (1991) 0.76
7-Methylguanine nucleotides and their structural analogues; protolytic equilibria, complexing with magnesium (II) ion and kinetics for alkaline opening of the imidazole ring. Acta Chem Scand B (1988) 0.76
Conformation of [8-arginine]vasopressin and V1 antagonists in dimethyl sulfoxide solution derived from two-dimensional NMR spectroscopy and molecular dynamics simulation. Eur J Biochem (1991) 0.76
Oxytocin induced cAMP-dependent protein kinase activation and urokinase-type plasminogen activator production in LLC-PK1 renal epithelial cells is mediated by the vasopressin V2-receptor. FEBS Lett (1993) 0.76
Identification of binding domains of pituitary adenylate cyclase activating polypeptide (PACAP) for its type 1 receptor by photoaffinity labeling. Ann N Y Acad Sci (1998) 0.75
Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance). Osteoporos Int (2015) 0.75
Synthesis of the central iron core of rubredoxin. J Am Chem Soc (1972) 0.75
Simple method for the synthesis of some boc-amino acids. Angew Chem Int Ed Engl (1972) 0.75
[Components of the green deathcap toadstool, amanita phalloides. XLII. Peptide syntheses. 48. Synthesis of norphalloin and of a monocyclic compound with 18-membered ring]. Justus Liebigs Ann Chem (1971) 0.75